Showing 1001-1010 of 1782 results for "".
- Rapid Respiratory Point-Of-Care Testing and Antibiotic Use in Primary Carehttps://reachmd.com/news/rapid-respiratory-point-of-care-testing-and-antibiotic-use-in-primary-care/2487458/Key Takeaways Same-day antibiotic prescribing was the same in both groups, with no overall difference in the primary outcome. Symptom severity, later antibiotic use, and subsequent healthcare seeking were similar across groups during follow-up.
- Endonasal Endoscopic Transethmoidal Transcribriform Approach: Technical Update and Practical Pointshttps://reachmd.com/news/endonasal-endoscopic-transethmoidal-transcribriform-approach-technical-update-and-practical-points/2485817/A recent technical note offers a stepwise update of the endonasal endoscopic transethmoidal transcribriform approach (EETTA) for midline anterior cranial fossa (ACF) lesions, describing it as a min
- Epcoritamab Study Points to Safer Outpatient Use in Relapsed/Refractory DLBCLhttps://reachmd.com/news/epcoritamab-study-points-to-safer-outpatient-use-in-relapsedrefractory-dlbcl/2483260/At the 2025 Society of Hematologic Oncology (SOHO) Annual Meeting,
- CRISPR Gene-Editing in GI Cancer: A Turning Point in Immunotherapyhttps://reachmd.com/news/crispr-gene-editing-in-gi-cancer-a-turning-point-in-immunotherapy/2474558/In the realm of gastrointestinal (GI) oncology, a groundbreaking clinical trial has demonstrated the potential of CRISPR/Cas9 gene-editing to enhance immune responses against advanced cancers. Conducted by the University of Minnesota, this study marks a pivotal moment in the int
- NIH-Led Studies Point to Potential Development of a Cataract Drughttps://reachmd.com/news/nih-led-studies-point-to-potential-development-of-a-cataract-drug/2468241/
- New Clues Point Towards How Exercise Reduces Symptoms of Depressionhttps://reachmd.com/news/new-clues-point-towards-how-exercise-reduces-symptoms-of-depression/2467613/The processes in the brain and body through which physical exercise reduces depressive symptoms have been explored by UCL researchers. Depression is the leading cause of disability worldwide and is associated with disruptions to several brain and psychological processes,
- Genetic Study Points to Oxytocin as Possible Treatment for Obesity and Postnatal Depressionhttps://reachmd.com/news/genetic-study-points-to-oxytocin-as-possible-treatment-for-obesity-and-postnatal-depression/2467238/Obesity and postnatal depression are significant global health problems. Postnatal depression affects more than one in 10 women within a year of giving birth and is linked to an increased risk of suicide, which accounts for as many as one in five maternal deaths in high income countries
- Study Reveals Role of Iron in Allergic Asthma and Points to Potential New Therapieshttps://reachmd.com/news/study-reveals-role-of-iron-in-allergic-asthma-and-points-to-potential-new-therapies/2462992/Image on the left shows inflammation caused by activated ILC2s in the lungs while image on the right shows inflammation reduced by treatment with iron chelator Deferiprone. Credit: 2024 H
- AGA Announces a 12-Point Plan to Address Barriers to IBD Carehttps://reachmd.com/news/aga-announces-a-12-point-plan-to-address-barriers-to-ibd-care/2462336/The goal of treatment for inflammatory bowel disease (IBD), including ulcerative colitis (UC), is to achieve and sustain remission. This requires coordinated efforts between a multidisciplinary team of experts, including gastroenterologists, surgeons, nurses, mental health profes
- Nanomedicine Advancement Shows Potential for Personalized Point-of-Care Therapeuticshttps://reachmd.com/news/nanomedicine-advancement-shows-potential-for-personalized-point-of-care-therapeutics/2457070/The 3D-printed T-mixed used in the study. Credit: University of Oklahoma. Stefan Wilhelm, an associate professor in the Stephen